news
METIS meets primary endpoint
The phase 3 METIS clinical trial demonstrated a statistically significant improvement in time to intracranial progression for patients treated with Tumor Treating Fields therapy and supportive care compared to supportive care alone in the treatment of patients with brain metastases from non-small cell lung cancer following stereotactic radiosurgery.
learn moreMay is #OncologyNursingMonth, and May 12 is #InternationalNursesDay. We are grateful for the empathy and drive of nurses and nurse practitioners worldwide. Karin Gottwald is a German nurse that has joined us on our patient-forward mission. Read her story: https://www.novocure.com/stories/karin-gottwald-we-live-our-patient-forward-mission/
We have entered into a new five-year up to $400.0 million committed senior secured credit facility with funds managed by Pharmakon Advisors, LP. https://www.novocure.com/novocure-secures-new-400-million-multi-tranche-non-dilutive-debt-financing-from-pharmakon/
We reported financial results for the quarter ended March 31, 2024, including quarterly net revenues of $139 million, up 13% year-over-year. Among the highlights: Active GBM patients increased by 11%. https://www.novocure.com/novocure-reports-first-quarter-2024-financial-results/#earnings $NVCR
As we pursue our patient-forward mission, we are committed to driving positive change on environmental, social, governance and corporate responsibility issues. Learn more about our most recent efforts in our 2024 Corporate Responsibility report: https://www.novocure.com/wp-content/uploads/2024/04/2024_novocure_corp_resp_rep_04_22_final-1.pdf
Jennifer continues to train in karate while facing glioblastoma. We are inspired by her resolve. Thanks, @6abc, for sharing this story!
#patientforward #GBM #btsm #TTFields
We are proud to share that the results of the METIS phase 3 clinical trial in brain metastases from non-small cell lung cancer will be presented at the @ASCO Annual Meeting. Learn more: https://www.novocure.com/Results-of-Novocures-METIS-Phase-3-Clinical-Trial-for-Patients-with-Brain-Metastasis-from-Non-Small-Cell-Lung-Cancer-to-be-Presented-as-Late-Breaking-Abstract-at-ASCO-2024/ #brainmetastases #lungcancer #clinicaltrials